Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqGS - Nasdaq Real Time Price • USD Fortrea Holdings Inc. (FTRE) Follow Compare 13.85 -0.20 (-1.42%) At close: February 28 at 4:00:02 PM EST 13.85 -0.00 (-0.00%) After hours: February 28 at 6:19:11 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Fortrea to Add Erin L. Russell to Board of Directors Fortrea and Starboard enter into Cooperation AgreementDURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L. Russell, a financial and healthcare executive, as a new independent member of the Company’s Board of Directors (the “Board”) effective immediately prior to the next regularly scheduled meeting of the Board. Ms. Russell is being appointed in connection with a cooperation agr Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research Fortrea to Sponsor SCRS’ Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical TrialsDURHAM, N.C., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Society for Clinical Research Sites (SCRS) and Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), are pleased to announce Fortrea’s sponsorship of the SCRS Collaborate Forward working group. Comprising 16 leading Global Impact Partner organizations, the Collaborate Forward working group will explore Several Insiders Invested In Fortrea Holdings Flagging Positive News When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase... Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call DURHAM, N.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2024 financial results before the market opens on Monday, March 3, 2025. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea downgraded to Neutral from Outperform at Baird Baird downgraded Fortrea (FTRE) to Neutral from Outperform with a price target of $25, down from $28. The firm says the company “abruptly cancelled” two conferences and its planned new deal roadshow. Given ongoing concerns around the sector, Fortrea’s “choppy” history post spin, and lack of clarity on the abrupt communications course change, Baird says it cannot recommend an actionable investment. “Perhaps there is a takeout looming, perhaps there is bad news looming, perhaps this will all pass Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors Carl Hull to Retire as Executive ChairmanSAN DIEGO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive Chairman of the Board and that the Board of Directors has unanimously elected R. Andrew Eckert to succeed him as Chairman of the Board, effective December 5, 2024. Carl H Fortrea to Present at the Citi Global Healthcare Conference DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Citi Global Healthcare Conference on Wednesday, December 4, 2024 at 1:45 pm ET. The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be availa Fortrea to Present at the Evercore HealthCONx Conference DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Evercore HealthCONx Conference on Thursday, December 5, 2024 at 10:00 am ET. The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available US$24.56 - That's What Analysts Think Fortrea Holdings Inc. (NASDAQ:FTRE) Is Worth After These Results Shareholders will be ecstatic, with their stake up 35% over the past week following Fortrea Holdings Inc. 's... Fortrea price target raised to $30 from $28 at Baird Baird raised the firm’s price target on Fortrea (FTRE) to $30 from $28 and keeps an Outperform rating on the shares. The firm expects superlative EPS growth and recovery, particularly in 2H25 and believes they’ll get through TSA and spin transitions in early 2025, with revenue growth resumption, cost leverage, and better interest expense additive. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on Fortrea Holdings Third Quarter 2024 Earnings: EPS Beats Expectations Fortrea Holdings ( NASDAQ:FTRE ) Third Quarter 2024 Results Key Financial Results Revenue: US$674.9m (down 13% from 3Q... Fortrea Holdings Inc (FTRE) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... Despite revenue decline, Fortrea Holdings Inc (FTRE) showcases strong demand with a solid book-to-bill ratio and promising growth prospects. Fortrea Stock Explodes 37%--Investors Are Eyeing Massive Gains Q3 Results Beat Expectations with Strong Momentum, Record Backlog, and a Bright Revenue Outlook Fortrea Reports Third Quarter 2024 Results For the three months ended September 30, 2024, from continuing operations: Revenues of $674.9 millionGAAP net loss of $(18.5) millionAdjusted EBITDA of $64.2 millionGAAP and adjusted net income (loss) per diluted share of $(0.21) and $0.23, respectivelyBook-to-bill ratio of 1.23x, resulting in 1.15x book-to-bill for the trailing 12 months DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today reported Fortrea Releases Inaugural Corporate Social Responsibility Report DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate Social Responsibility report, “Fortrea for Better.” Available for download on Fortrea.com, the report describes Fortrea’s environmental, social and governance (ESG) activities, reported across four distinct sections: Fortrea for Life: Responsible Environmental PracticesFortrea for All: Responsible People Pr Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call DURHAM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third quarter 2024 financial results before the market opens on Friday, November 8, 2024. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea In Fortrea Holdings Second Quarter 2024 Earnings: Misses Expectations Fortrea Holdings ( NASDAQ:FTRE ) Second Quarter 2024 Results Key Financial Results Revenue: US$662.4m (down 8.6% from... Insider Stock Buying Reaches US$1.08m On Fortrea Holdings Multiple insiders secured a larger position in Fortrea Holdings Inc. ( NASDAQ:FTRE ) shares over the last 12 months... Fortrea Reports Second Quarter 2024 Results For the three months ended June 30, 2024, from continuing operations: Revenues of $662.4 millionGAAP net loss of $(99.3) millionAdjusted EBITDA of $55.2 millionGAAP and adjusted diluted loss per share of $(1.11) and $(0.03), respectivelyBook-to-bill ratio of 0.96x, resulting in 1.16x book-to-bill for the trailing 12 monthsCompleted divestiture of assets relating to the Endpoint Clinical and Patient Access businessesDebt paydown of $504 million in the quarter using initial divestiture and securit Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Inve Performance Overview Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return FTRE S&P 500 YTD -25.74% +1.24% 1-Year -63.02% +17.45% 3-Year -58.17% +36.14%